A combination of methotrexate and zoledronic acid prevents bone erosions and systemic bone mass loss in collagen induced arthritis

Le Goff, B., Soltner, E., Charrier, C. et al. (4 more authors) (2009) A combination of methotrexate and zoledronic acid prevents bone erosions and systemic bone mass loss in collagen induced arthritis. Arthritis Research & Therapy, 11 (6). R185. ISSN 1478-6354

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2009 Le Goff et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Keywords: Absorptiometry; Photon; Animals; Antirheumatic Agents; Arthritis; Experimental; Arthritis; Rheumatoid; Bone and Bones; Diphosphonates; Drug Therapy; Combination; Female; Imidazoles; Immunohistochemistry; Methotrexate; Osteoclasts; Rats; Rats, Sprague-Dawley; Tomography; X-Ray Computed
Dates:
  • Published: 10 December 2009
  • Accepted: 10 December 2009
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 12 Apr 2016 13:42
Last Modified: 23 Apr 2016 05:35
Published Version: http://dx.doi.org/10.1186/ar2877
Status: Published
Publisher: BioMed Central
Refereed: Yes
Identification Number: https://doi.org/10.1186/ar2877
Related URLs:

Download

Filename: A combination of methotrexate and zoledronic acid prevents bone erosions and systemic bone mass loss in collagen induced arthritis..pdf

Share / Export

Statistics